ONS ONCC CHEMO RENEWAL 2025 ONCOLOGY EXAMS
QUESTIONS AND ANSWERS 100% CORRECT!!
, Main benefit of neoadjuvant chemotherapy (breast cancer patient) - ANSWER
Neoadjuvant therapy does not increase survival when compared to adjuvant therapy. It
only changes the timing of treatment and can change surgical options if the tumor is
shrunk enough. If this occurs, the patient may only require a lumpectomy plus radiation
therapy instead of needing a mastectomy
Due to Mrs. Turner's age and comorbidities, her oncologist performs a comprehensive
geriatric assessment. You know that this assessment covers all but which of the
following: - ANSWER A comprehensive geriatric assessment (CGA) is a
multidisciplinary evaluation to assess life expectancy and risk of morbidity and mortality
in the older patient. This assessment tool would evaluate and include the following
areas: functional status, socioeconomic issues, psychosocial distress, comorbidities,
cognitive function, nutritional status, polypharmacy, and a medication review (NCCN
Older Adult Oncology Guidelines, version 1.2015).
The NCCN Older Adult Oncology Guidelines (version 1.2015) provides information on
what is included in a comprehensive geriatric assessment. Currently, more than 60% of
cancers in the United States occur in people age ______and older and as the oncology
world ages, nearly half (46%) of cancer survivors are 70 years of age or older -
ANSWER 65
What is your best explanation for why Mrs. Turner was given a port to receive her
chemotherapy? - ANSWER Two of the agents (docetaxel and carboplatin) that Mrs.
Turner will receive are categorized as irritants. Docetaxel can cause a significant
reaction if it extravasates. It can lead to edema, erythema, occasional pain and blister
formation (ONS Chemo/Bio guidelines, 2014). That is the most likely reason that Mrs.
Turner was given a port for her treatments. Some patients will receive their treatments
through a peripheral IV without incident. Just because they are intravenous agents does
not mean that a port is required and needing a port has nothing to do with her being
older in age. Since none of these agents are vesicants, they likely could have been
given safely via peripheral route but having a port placed is OK as well.
_____________can cause inflammation, pain, and burning but rarely cause tissue
necrosis comparable to a vesicant (unless a large amount or a very high concentration
of the irritant is extravasated). - ANSWER Irrirtants
_____________can cause blistering and significant pain and tissue damage and
destruction, leading to tissue death. - ANSWER Vesicants
QUESTIONS AND ANSWERS 100% CORRECT!!
, Main benefit of neoadjuvant chemotherapy (breast cancer patient) - ANSWER
Neoadjuvant therapy does not increase survival when compared to adjuvant therapy. It
only changes the timing of treatment and can change surgical options if the tumor is
shrunk enough. If this occurs, the patient may only require a lumpectomy plus radiation
therapy instead of needing a mastectomy
Due to Mrs. Turner's age and comorbidities, her oncologist performs a comprehensive
geriatric assessment. You know that this assessment covers all but which of the
following: - ANSWER A comprehensive geriatric assessment (CGA) is a
multidisciplinary evaluation to assess life expectancy and risk of morbidity and mortality
in the older patient. This assessment tool would evaluate and include the following
areas: functional status, socioeconomic issues, psychosocial distress, comorbidities,
cognitive function, nutritional status, polypharmacy, and a medication review (NCCN
Older Adult Oncology Guidelines, version 1.2015).
The NCCN Older Adult Oncology Guidelines (version 1.2015) provides information on
what is included in a comprehensive geriatric assessment. Currently, more than 60% of
cancers in the United States occur in people age ______and older and as the oncology
world ages, nearly half (46%) of cancer survivors are 70 years of age or older -
ANSWER 65
What is your best explanation for why Mrs. Turner was given a port to receive her
chemotherapy? - ANSWER Two of the agents (docetaxel and carboplatin) that Mrs.
Turner will receive are categorized as irritants. Docetaxel can cause a significant
reaction if it extravasates. It can lead to edema, erythema, occasional pain and blister
formation (ONS Chemo/Bio guidelines, 2014). That is the most likely reason that Mrs.
Turner was given a port for her treatments. Some patients will receive their treatments
through a peripheral IV without incident. Just because they are intravenous agents does
not mean that a port is required and needing a port has nothing to do with her being
older in age. Since none of these agents are vesicants, they likely could have been
given safely via peripheral route but having a port placed is OK as well.
_____________can cause inflammation, pain, and burning but rarely cause tissue
necrosis comparable to a vesicant (unless a large amount or a very high concentration
of the irritant is extravasated). - ANSWER Irrirtants
_____________can cause blistering and significant pain and tissue damage and
destruction, leading to tissue death. - ANSWER Vesicants
